Return cycle mapping: Have we come full cycle?  by Mahomed, Yousuf & Miller, John M.
son that one should attempt to minimize the amount
of additional damage done to eradicate the tissue
responsible for VT. The process of electrophysiologic
mapping has been a mainstay of surgical therapy for
VT in that it attempts to localize these critical areas of
the reentrant circuit, such that minimal incision,
resection, or ablation could effect antiarrhythmic suc-
cess. The more complete the mapping data, the better
the arrhythmia cure rate.1 However, in practice, map-
ping has several limitations (some of which are dis-
cussed herein), and because one cannot always be cer-
tain that all arrhythmogenic areas have been
identified, most surgeons use a generous resection or
cryoablation margin beyond areas indicated by map-
ping—even to the point of removing all visible endo-
cardial scar.2
Standard VT mapping and return cycle mapping
During standard VT mapping, one attempts to locate
areas of the endocardium from which diastolic poten-
tials (timing between the end of one VT QRS and the
next) are recorded. The central common pathway (CCP)
of the VT circuit should be in such an area, although
diseased tissue in other areas may masquerade as CCP
by having similar diastolic timing. These areas of great-
est interest are anatomically small (2-4 cm2), and
recordings from them have very low amplitudes and
Ventricular tachycardia (VT) occurring in patientswho have had a previous myocardial infarction has
been demonstrated to be due to reentry. Critical com-
ponents of this reentrant circuit—without which the
tachycardia cannot continue—have been shown to be
located within endocardial or subendocardial layers
of the infarct zone or its periphery. This is fortunate,
in that it allows a surgeon’s knife or an electrophysi-
ologist’s catheter to have access to critical compo-
nents of the VT circuit to incise, remove, or ablate
this relatively small amount of tissue and thereby
eliminate VT recurrences. In hearts that have already
sustained muscle loss from infarction, it stands to rea-
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great complexity, making their interpretation difficult.
Nitta and associates3 have attempted to circumvent
these problems with return cycle mapping. With this
technique, one uses a short burst of overdrive pacing
during VT (“entrainment”) and records the timing of
activation of large areas of endocardium during the first
2 beats of VT when it resumes after cessation of pac-
ing. An isochronal line connecting recording sites at
which the length of the return cycle equals the VT cycle
length can be plotted. When pacing is performed at sev-
eral different sites, a family of such isochrones is made;
Nitta’s group found that the point of intersection of
these lines is at the CCP.
Is the return cycle mapping technique valid? It seems
to reliably point to the entrance to the CCP. Nitta and col-
leagues3 have taken the necessary steps to validate the
technique by terminating VT with cryoablation at sites to
which they were directed by the return cycle mapping
method. If the technique is so good, are there any limita-
tions to its use? As it turns out, quite a few conditions
have to be met before return cycle mapping can be
applied successfully to yield its impressive results. Many
of these apply to standard mapping as well.
1. Sustained uniform VT must be inducible during
surgery. In at least 10% of cases, VT cannot be
induced and its occurrence cannot be predicted
before the procedure. Without sustained VT,
return cycle mapping cannot be applied at all.
2. VT must be entrainable; that is, overdrive pacing
during VT must capture the heart and the same VT
resume after pacing ceases. If VT terminates after
pacing or changes to a different morphology,
return cycle mapping cannot be used.
3. A large number of simultaneously recording elec-
trodes must be in the heart, some of which must
overlie the region of the CCP, to form the neces-
sary family of isochrones for return cycle map-
ping. This requires specialized equipment that is
not available at all centers.
4. It must be possible to pace and capture at multiple
sites, once again to form the set of isochrones
whose intersection is at the CCP.
5. Finally, not all forms of reentry have a CCP, and
the usefulness of return cycle mapping in such
cases is unclear.
Return cycle mapping has not yet been evaluated in
man; however, if the technique is validated in human
VT mapping and ablation, it could prove useful as an
additional tool. If a team of surgeons and electrophysi-
ologists then plans to use return cycle mapping to cure
a patient of VT, they can probably anticipate a good
result if all the aforementioned conditions are met.
However, they should also have contingency plans if
any one condition fails. Alternate techniques include
mapping areas of fragmented electrograms during
sinus rhythm if VT cannot be initiated4 or using stan-
dard activation mapping techniques if overdrive pacing
for return cycle mapping results in VT termination or
change in VT morphology.
The big picture 
Regardless of how useful return cycle mapping may
be, a larger question remains: Is it needed? This is very
much in doubt, because very few direct surgical proce-
dures are performed currently. This is not for lack of
good mapping techniques, but because alternatives
exist. These include the implantable cardioverter-defib-
rillator (ICD) and catheter ablation for VT. In particu-
lar, the ICD has largely supplanted surgical ablation for
therapy of VT by virtue of its superior peri-procedural
morbidity and mortality, high efficacy and reliability,
and ease of use. In cases of frequent VT episodes,
catheter ablation (especially combined with ICD thera-
py) provides very good palliation or even cure.5,6 There
are still circumstances in which neither of these thera-
pies is reasonable and mapping-directed therapy for VT
is preferable.7,8 These include very frequent or inces-
sant, hemodynamically poorly tolerated VT, known left
ventricular thrombus (precluding catheter ablation),
patient preference (potential for surgical cure rather
than palliation), and the need for concomitant revascu-
larization or valve surgery.
On this last point, most authorities believe that intra-
operative VT mapping and ablation adds significant
time and perhaps morbidity to the procedure.7,9,10 This
concern raises the question of whether patients who
have known risk factors for VT (prior infarction, espe-
cially with a left ventricular aneurysm) and are under-
going revascularization or valve surgery should have
concomitant attempts at VT mapping and ablation or
whether they should simply have an ICD inserted. In
patients who have had preoperative spontaneous
episodes of VT (and perhaps even syncope, which may
have been caused by VT), concomitant arrhythmia
surgery is usually warranted to prevent very frequent
VT recurrences in the postoperative period.11 Because
such cases are infrequent, once identified they should
probably be referred to a center that maintains the
required equipment and expertise to provide the best
possible environment for surgery. In patients who have
not yet had spontaneous arrhythmia episodes, the
answer is less certain. Preoperative electrophysiologic
study may clarify this, if it can be performed safely.12
Further complicating the decision is the fact that, for
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most surgical endocardial mapping and ablation tech-
niques, an open ventricle is necessary—and, along with
it, cardiopulmonary bypass. With increasingly frequent
use of off-pump and minimally invasive revasculariza-
tion techniques, adding an open-ventricle procedure
negates the advantages of these techniques.
If return cycle mapping has missed its chance to
make a major difference in surgical therapy of VT, per-
haps it will have substantial application in endocardial
catheter mapping of both ventricular and atrial
macroreentrant arrhythmias (such as those occurring
after atriotomy for septal defect or atrioventricular
valve repair). Return cycle mapping could be used in
conjunction with multipolar mapping systems such as
noncontact arrays or basket contact catheters to local-
ize the entrance to CCPs of these arrhythmias.13,14 To
our knowledge, this technique has not yet been applied
in these situations.
It is unlikely that return cycle mapping—or any map-
ping technique, for that matter—will ever replace the
ICD for treatment of VT.8 If anything, ICD therapy is
becoming more appealing because of the continued
decrease in device size and increase in battery life, ease
of implantation, reliability, and feature set. Surgery, on
the other hand, continues to have a moderate operative
morbidity and mortality and is not uniformly success-
ful. In carefully selected cases,7,9 however, intraopera-
tive mapping—perhaps with return cycle mapping—
and surgical therapy can provide a very good outcome.
Thus, although this new technique may not result in
therapy for VT coming “full cycle” and returning to its
origins in the operating room, it nonetheless offers new
insights and options, which are always good to have. 
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